Intracranial artery stenosis is associated with cortical thinning in stroke-free individuals of two longitudinal cohorts
- PMID: 36577280
- PMCID: PMC9880900
- DOI: 10.1016/j.jns.2022.120533
Intracranial artery stenosis is associated with cortical thinning in stroke-free individuals of two longitudinal cohorts
Abstract
Background: We examined the association between asymptomatic intracranial artery stenosis (aICAS) and cortical thickness using brain magnetic resonance morphometry in two cohorts.
Methods: This cross-sectional study included stroke-free participants from the Northern Manhattan Study (NOMAS) and the National Alzheimer's Coordinating Center (NACC). We represented the predictor aICAS in NOMAS as a continuous global stenosis score reflecting an overall burden of stenosis (possible range 0-44) assessed by magnetic resonance angiography and in NACC as a dichotomous autopsy-determined Circle of Willis (CoW) atherosclerosis (none-mild vs moderate-severe). The primary outcome of interest was total cortical thickness. We analyzed each dataset separately using multivariable linear regression.
Results: The analysis included 1209 NOMAS (46% had any stenosis, 5% had ≥70% stenosis of at least one vessel; stenosis score range 0-11) and 392 NACC (36% moderate-severe CoW atherosclerosis) participants. We found an inverse relationship between stenosis score and total cortical thickness (β-estimate [95% confidence interval (CI)]: -2.98 [-5.85, -0.11]) in adjusted models. We replicated these results in NACC (β-estimate [95% CI]: -0.06 [-0.11, -0.003]). Post-hoc, we segregated stenosis scores by location and only posterior circulation stenosis score was associated with total cortical thickness (anterior β-estimate [95% CI]: -0.90 [-5.16, 3.36], posterior β-estimate [95% CI]: -7.25 [-14.30, -0.20]).
Conclusion: We found both radiographically and neuropathologically determined aICAS to be associated with global cortical thinning. Interestingly, posterior circulation stenoses appeared to drive this association with global cortical thinning, raising the possibility of pathophysiologic mechanisms for cortical thinning other than impaired hemodynamics.
Keywords: Cortical thickness; Intracranial artery stenosis; Magnetic resonance imaging; Neurodegeneration.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest AVM is on the Steering Committee of the Alzheimer's disease Cooperative Study and is a council member for the Alzheimer's Association International Research Grants Program. DY, FK, TR, CW, ME, RS, and JG have no relevant conflicts of interest to disclose.
Figures
Similar articles
-
Association between symptomatic intracranial atherosclerotic disease and the integrity of the circle of Willis.J Integr Neurosci. 2022 Jan 20;21(1):2. doi: 10.31083/j.jin2101002. J Integr Neurosci. 2022. PMID: 35164438
-
Physical Activity Is Inversely Associated With Severe Intracranial Stenosis in Stroke-Free Participants of NOMAS.Stroke. 2023 Jan;54(1):159-166. doi: 10.1161/STROKEAHA.122.039660. Epub 2022 Nov 23. Stroke. 2023. PMID: 36416126 Free PMC article.
-
Intracranial Large Artery Stenosis and Past Infectious Exposures: Results From the NOMAS Cohort.Stroke. 2022 May;53(5):1589-1596. doi: 10.1161/STROKEAHA.121.036793. Epub 2022 Feb 2. Stroke. 2022. PMID: 35105181 Free PMC article.
-
Co-existing intracranial and extracranial carotid artery atherosclerotic plaques and recurrent stroke risk: a three-dimensional multicontrast cardiovascular magnetic resonance study.J Cardiovasc Magn Reson. 2016 Dec 2;18(1):90. doi: 10.1186/s12968-016-0309-3. J Cardiovasc Magn Reson. 2016. PMID: 27908279 Free PMC article.
-
Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke.Cerebrovasc Dis Extra. 2016 Jan 20;6(1):1-11. doi: 10.1159/000443338. eCollection 2016 Jan-Apr. Cerebrovasc Dis Extra. 2016. PMID: 26997949 Free PMC article.
Cited by
-
Intracranial atherosclerotic disease and neurodegeneration: a narrative review and plausible mechanisms.J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108015. doi: 10.1016/j.jstrokecerebrovasdis.2024.108015. Epub 2024 Sep 18. J Stroke Cerebrovasc Dis. 2024. PMID: 39303868 Review.
-
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration.Medicina (Kaunas). 2023 Mar 4;59(3):504. doi: 10.3390/medicina59030504. Medicina (Kaunas). 2023. PMID: 36984505 Free PMC article.
References
-
- Suri MFK, Qiao Y, Ma X, Guallar E, Zhou J, Zhang Y, Liu L, Chu H, Qureshi AI, Alonso A, Folsom AR, Wasserman BA. Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the Atherosclerosis Risk in Communities Study. Stroke 2016;47:1187–93. - PMC - PubMed
-
- Zhu J, Wang Y, Li J, Deng J, Zhou H. Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease. Neurology 2014;82:842–9. - PubMed
Publication types
MeSH terms
Grants and funding
- P50 AG005142/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- P50 AG047266/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- R01 AG057709/AG/NIA NIH HHS/United States
- R01 NS029993/NS/NINDS NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- P50 AG047366/AG/NIA NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- P30 AG053760/AG/NIA NIH HHS/United States
- P30 AG062428/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- P30 AG072946/AG/NIA NIH HHS/United States
- R56 NS029993/NS/NINDS NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P30 AG066512/AG/NIA NIH HHS/United States
- P30 AG062421/AG/NIA NIH HHS/United States
- T32 NS007153/NS/NINDS NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P50 AG047270/AG/NIA NIH HHS/United States
- P30 AG062429/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- P30 AG049638/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- R37 NS029993/NS/NINDS NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- P30 AG066509/AG/NIA NIH HHS/United States
- P30 AG062715/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- P30 AG072947/AG/NIA NIH HHS/United States
- R01 AG066162/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical